tradingkey.logo
tradingkey.logo
Search

Benitec Biopharma Inc

BNTC
Add to Watchlist
9.640USD
-0.190-1.93%
Close 09-24 16:00(ET)
331.13MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.93%

5 Days

-15.14%

1 Month

-24.15%

6 Months

-9.91%

Year to Date

-28.43%

1 Year

-31.58%

Key Figures

9.740Open
10.410High
10.06KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
9.830Prev. Close
9.255Low
96.40KTurnover
LossP/E Static
1.87P/B
0.00%Div Yield TTM
-28.43%ROA
16.76052wk High
14.33Volume Ratio
-37.92MNet Profit
34.35MShares
-0.9227EPS TTM
0.28Beta
-29.58%ROE
9.25552wk Low
20.96%Amplitude
100.00%Gross Margin
331.13MMarket Cap
1.41Reward/Risk
3.73%Risk Rate
More news coming soon, stay tuned...

Benitec Biopharma Inc's Score

0.08vs previous score
Forecast8.86
Financial Health6.60
Technical4.98
Valuation Dimensions8.50
Institutional Confidence10.00
Risk Assessment3.67

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
24.333Target Price
+147.54%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy32444444
Buy44333334
Hold00000000
Sell00000000
Strong Sell00000000

Benitec Biopharma Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q4
Earnings / Forecast
-0.26/-0.27
Revenue / Forecast
--/0.00

Benitec Biopharma Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolBNTC
Number of employees19
CountryUnited States of America

Ownership

ShareholdersProportion
Suvretta Capital Management, LLC33.71%
Janus Henderson Investors8.50%
Franklin Advisers, Inc.6.41%
Adage Capital Management, L.P.6.19%
Shareholder TypesProportion
Hedge Fund53.49%
Investment Advisor/Hedge Fund19.59%
Investment Advisor17.32%
Venture Capital5.40%

FAQs

What is the current price of Benitec Biopharma Inc (BNTC)?

The current price of Benitec Biopharma Inc (BNTC) is 9.64.

What is the symbol of Benitec Biopharma Inc?

The ticker symbol of Benitec Biopharma Inc is BNTC.

What is the 52-week high of Benitec Biopharma Inc?

The 52-week high of Benitec Biopharma Inc is 16.76.

What is the 52-week low of Benitec Biopharma Inc?

The 52-week low of Benitec Biopharma Inc is 9.26.

What is the market capitalization of Benitec Biopharma Inc?

The market capitalization of Benitec Biopharma Inc is 331.13M.

Is Benitec Biopharma Inc (BNTC) currently rated as Buy, Hold, or Sell?

According to analysts, Benitec Biopharma Inc (BNTC) has an overall rating of Buy, with a price target of 24.33.

What is the Earnings Per Share (EPS TTM) of Benitec Biopharma Inc (BNTC)?

The Earnings Per Share (EPS TTM) of Benitec Biopharma Inc (BNTC) is -0.92.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.